AAAAAA
Results:
1-22
|
Results: 22
Authors:
Fenaux, P
Chomienne, C
Degos, L
Citation: P. Fenaux et al., Treatment of acute promyelocytic leukaemia, BEST P R C, 14(1), 2001, pp. 153-174
Authors:
Degos, L
Wang, ZY
Citation: L. Degos et Zy. Wang, All trans retinoic acid in acute promyelocytic leukemia, ONCOGENE, 20(49), 2001, pp. 7140-7145
Authors:
Degos, L
Citation: L. Degos, Acute promyelocytic leukemia: A first model for multiple processes, SEM HEMATOL, 38(1), 2001, pp. 1-3
Authors:
Fenaux, P
Chomienne, C
Degos, L
Citation: P. Fenaux et al., All-trans retinoic acid and chemotherapy in the treatment of acute promyelocytic leukemia, SEM HEMATOL, 38(1), 2001, pp. 13-25
Authors:
Cassinat, B
Chevret, S
Zassadowski, F
Balitrand, N
Guillemot, I
Menot, ML
Degos, L
Fenaux, P
Chomienne, C
Citation: B. Cassinat et al., In vitro all-trans retinoic acid sensitivity of acute promyelocytic leukemia blasts: a novel indicator of poor patient outcome, BLOOD, 98(9), 2001, pp. 2862-2864
Authors:
Fiere, D
Vernant, JP
Michallet, M
Degos, L
Leblond, V
Olteanu, N
Boucheix, C
Charrin, C
Varet, B
Huguet, FR
Delannoy, A
Gratecos, N
Lepage, E
Sebban, C
Citation: D. Fiere et al., Treatment of adult acute lymphoblastic leukemia long term results of a prospective study: LALA 87, HEMAT BLOOD, 40, 2001, pp. 389-392
Authors:
Cassinat, B
Chevret, S
Balitrand, N
Zassowski, F
Barbey, C
Degos, L
Fenaux, P
Chomienne, C
Citation: B. Cassinat et al., APL biology, HEMAT BLOOD, 40, 2001, pp. 555-561
Authors:
Thiebaut, A
Vernant, JP
Degos, L
Huguet, FR
Reiffers, J
Sebban, C
Lepage, E
Thomas, X
Fiere, D
Citation: A. Thiebaut et al., Adult acute lymphocytic leukemia study testing chemotherapy and autologousand allogeneic transplantation - A follow-up report of the French protocolLALA 87, HEMAT ONCOL, 14(6), 2000, pp. 1353
Authors:
Fenaux, P
Chevret, S
Guerci, A
Fegueux, N
Dombret, H
Thomas, X
Sanz, M
Link, H
Maloisel, F
Gardin, C
Bordessoule, D
Stoppa, AM
Sadoun, A
Muus, P
Wandt, H
Mineur, P
Whittaker, JA
Fey, M
Daniel, MT
Castaigne, S
Degos, L
Citation: P. Fenaux et al., Long-term follow-up confirms the benefit of all-trans retinoic acid in acute promyelocytic leukemia, LEUKEMIA, 14(8), 2000, pp. 1371-1377
Authors:
Thomas, X
Dombret, H
Cordonnier, C
Pigneux, A
Gardin, C
Guerci, A
Vekhoff, A
Sadoun, A
Stamatoullas, A
Fegueux, N
Maloisel, F
Cahn, JY
Reman, O
Gratecos, N
Berthou, C
Huguet, F
Kotoucek, P
Travade, P
Buzyn, A
de Revel, T
Vilque, JP
Naccache, P
Chomienne, C
Degos, L
Fenaux, P
Citation: X. Thomas et al., Treatment of relapsing acute promyelocytic leukemia by all-trans retinoic acid therapy followed by timed sequential chemotherapy and stem cell transplantation, LEUKEMIA, 14(6), 2000, pp. 1006-1013
Authors:
Cassinat, B
Zassadowski, F
Balitrand, N
Barbey, C
Rain, JD
Fenaux, P
Degos, L
Vidaud, M
Chomienne, C
Citation: B. Cassinat et al., Quantitation of minimal residual disease in acute promyelocytic leukemia patients with t(15;17) translocation using real-time RT-PCR, LEUKEMIA, 14(2), 2000, pp. 324-328
Authors:
de Botton, S
Chevret, S
Sanz, M
Dombret, H
Thomas, X
Guerci, A
Fey, M
Rayon, C
Huguet, F
Sotto, JJ
Gardin, C
Makhoul, PC
Travade, P
Solary, E
Fegueux, N
Bordessoule, D
San Miguel, J
Link, H
Desablens, B
Stamatoullas, A
Deconinck, E
Geiser, K
Hess, U
Maloisel, F
Castaigne, S
Preudhomme, C
Chomienne, C
Degos, L
Fenaux, P
Citation: S. De Botton et al., Additional chromosomal abnormalities in patients with acute promyelocytic leukaemia (APL) do not confer poor prognosis: results of APL 93 trial, BR J HAEM, 111(3), 2000, pp. 801-806
Authors:
Adida, C
Recher, C
Raffoux, E
Daniel, MT
Taksin, AL
Rousselot, P
Sigaux, F
Degos, L
Altieri, DC
Dombret, H
Citation: C. Adida et al., Expression and prognostic significance of survivin in de novo acute myeloid leukaemia, BR J HAEM, 111(1), 2000, pp. 196-203
Authors:
Aslangul-Castier, E
Papo, T
Amoura, Z
Baud, O
Leblond, V
Charlotte, F
Bricaire, F
Degos, L
Piette, JC
Citation: E. Aslangul-castier et al., Systemic vasculitis with bilateral perirenal haemorrhage in chronic myelomonocytic leukaemia, ANN RHEUM D, 59(5), 2000, pp. 390-393
Authors:
Bastie, JN
Cazals-Hatem, D
Daniel, MT
D'Agay, MF
Rabian, CL
Glaisner, S
Noel-Walter, MP
Dabout, D
Flandrin, G
Dombret, H
Poisson, D
Degos, L
Castaigne, S
Citation: Jn. Bastie et al., Five years follow-up after 2-chloro deoxyadenosine treatment in thirty patients with hairy cell leukemia: Evaluation of minimal residual disease and CD4+lymphocytopenia after treatment, LEUK LYMPH, 35(5-6), 1999, pp. 555-565
Authors:
Koken, MHM
Daniel, MT
Gianni, M
Zelent, A
Licht, J
Buzyn, A
Minard, P
Degos, L
Varet, B
de The, H
Citation: Mhm. Koken et al., Retinoic acid, but not arsenic trioxide, degrades the PLZF/RAR alpha fusion protein, without inducing terminal differentiation or apoptosis, in a RA-therapy resistant t(11;17)(q23;q21) APL patient, ONCOGENE, 18(4), 1999, pp. 1113-1118
Authors:
Larghero, J
Zassadowski, F
Rousselot, P
Padua, RA
Degos, L
Chomienne, C
Citation: J. Larghero et al., Alteration of the PML proto-oncogene in leukemic cells does not abrogate expression of MHC class I antigens, LEUKEMIA, 13(8), 1999, pp. 1295-1296
Authors:
Carpentier, AF
Leonard, N
Lacombe, J
Zassadowski, F
Padua, RA
Degos, L
Daumas-Duport, C
Chomienne, C
Citation: Af. Carpentier et al., Retinoic acid modulates RAR alpha and RAR beta receptors in human glioma cell lines, ANTICANC R, 19(4B), 1999, pp. 3189-3192
Authors:
Lallemand-Breitenbach, V
Guillemin, MC
Janin, A
Daniel, MT
Degos, L
Kogan, SC
Bishop, JM
de The, H
Citation: V. Lallemand-breitenbach et al., Retinoic acid and arsenic synergize to eradicate leukemic cells in a mousemodel of acute promyelocytic leukemia, J EXP MED, 189(7), 1999, pp. 1043-1052
Authors:
Fenaux, P
Chastang, C
Chevret, S
Sanz, M
Dombret, H
Archimbaud, E
Fey, M
Rayon, C
Huguet, F
Sotto, JJ
Gardin, C
Makhoul, PC
Travade, P
Solary, E
Fegueux, N
Bordessoule, D
San Miguel, J
Link, H
Desablens, B
Stamatoullas, A
Deconinck, E
Maloisel, F
Castaigne, S
Preudhomme, C
Degos, L
Citation: P. Fenaux et al., A randomized comparison of all transretinoic acid (ATRA) followed by chemotherapy and ATRA plus chemotherapy and the role of maintenance therapy in newly diagnosed acute promyelocytic leukemia, BLOOD, 94(4), 1999, pp. 1192-1200
Authors:
Chevret, S
Degos, L
Fenaux, P
Citation: S. Chevret et al., Rate requested from the subgroups studied in the APL93 trial - Response, BLOOD, 94(11), 1999, pp. 3958-3958
Authors:
Degos, L
Citation: L. Degos, Acute promyelocytic leukaemia, TEXTBOOK OF MALIGNANT HAEMATOLOGY, 1999, pp. 771-786
Risultati:
1-22
|